Skip to main content
Back to K2VC

K2VC's Pharmaceutical Portfolio

Browse 5 Pharmaceutical companies funded by K2VC. See funding amounts, founder contacts, and investment details.

Pharmaceutical Companies
5
Total Funding in Pharmaceutical
$51.9M

Pharmaceutical Portfolio Companies (5)

Export
BiotechnologyPharmaceutical

Aureka Biotechnologies is a pioneering biotech firm dedicated to democratizing the pharmaceutical sector in order to conquer sickness.

Laguna Hills, United States
April 2026
$23.4M
Series A

Founder Contacts

19,000+ verified contacts

BiotechnologyHealth CareOncologyPharmaceutical

Apollomics is a biopharmaceutical company discovering and developing mono- and combination- oncology therapies to harness the immune system.

Foster City, United States
September 2025
$4.1M
Post Ipo Equity

Founder Contacts

19,000+ verified contacts

BiotechnologyPharmaceuticalTherapeutics

Phanes Therapeutics is a biotech company focused on discovery and development of therapeutics for solid tumors and eye diseases

San Diego, United States
January 2024
Series Unknown

Founder Contacts

19,000+ verified contacts

BiopharmaBiotechnologyPharmaceutical

Renjing Biotech is engaged in the research and development of drugs based on messenger ribonucleic acid.

Suzhou, China
February 2023
$14.4M
Seed

Founder Contacts

19,000+ verified contacts

Artificial Intelligence (AI)BiotechnologyHealth CarePharmaceutical

Regenerative Bio is the world's first anti-aging biotechnology company driven by artificial intelligence and cloud supercomputing.

Cambridge, United States
February 2022
$10.0M
Angel

Founder Contacts

19,000+ verified contacts

Explore K2VC's Full Portfolio

View all companies funded by K2VC across every industry and funding stage.

View Full K2VC Portfolio